Page 766 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 11

355. Young D, Lamb SE, Shah S, et al. High-frequency oscilla- 373. Merritt TA, Hallman M, Bloom BT, et al. Prophylactic treatment
tion for acute respiratory distress syndrome. N Engl J Med. of very premature infants with human surfactant. N Engl J Med.
2013;368:806. 1986;315:785.
356. Ferguson ND, Cook DJ, Guyatt GH, et al. High-frequency 374. Horbar JD, Soll RF, Sutherland JM, et al. A multicenter, ran-
oscillation in early acute respiratory distress syndrome. N Engl J domized, placebo-controlled trial of surfactant therapy for
Med. 2013;368:795. respiratory distress syndrome. N Engl J Med. 1989;320:959.
357. Holzapfel L, Robert D, Perrin F, et al. Comparison of high 375. Spragg RG, Lewis JF, Wurst W, et al. Treatment of acute respira-
frequency jet ventilation to conventional ventilation in adults tory distress syndrome with recombinant surfactant protein C
with respiratory distress syndrome. Intensive Care Med. 1987; surfactant. Am J Respir Crit Care Med. 2003;167:1562.
13:100. 376. Seeger W, Hafner D, Lewis JF, et al. Treatment with rSP-C
358. Carlon GC, Howland WS, Ray C, et al. High frequency jet venti- surfactant reduces mortality in ARDS due to primary
lation: a prospective randomized evaluation. Chest. 1983;84:551. pulmonary events (Abstract). Am J Respir Crit Care Med.
359. Schuster DP, Klain M, Snyder JV. Comparison of high frequency 2002;165:A219.
jet ventilation to conventional ventilation during severe acute 377. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant
respiratory failure in humans. Crit Care Med. 1982;10:625. therapy for patients with acute respiratory distress syndrome.
360. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane Am J Respir Crit Care Med. 1997;155:1309.
oxygenation in severe acute respiratory failure: a randomized 378. Spragg RG, Lewis JF, Walmrath H-D, et al. Effect of recombi-
prospective study. JAMA. 1979;242:2193. nant surfactant protein C-based surfactant on the acute respira-
361. Egan TM, Duffin J, Glynn MF, et al. Ten-year experience with tory distress syndrome. N Engl J Med. 2004;351:884.
extracorporeal membrane oxygenation for severe respiratory 379. Spragg RG, Friedemann JHT, Lewis JF, et al. Recombinant
failure. Chest. 1988;94:681. surfactant protein C-based surfactant for patients with severe
362. Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency direct lung injury. Am J Respir Crit Care Med. 2011;183:1055.
positive-pressure ventilation with extracorporeal CO removal 380. Looney MR, Nguyen JX, Hu Y, et al. Platelet depletion and aspi-
2
in severe acute respiratory failure. JAMA. 1986;256:881. rin treatment protect mice in a two-event model of transfusion-
363. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical related acute lung injury. J Clin Invest. 2009;119:3450.
trial of pressure controlled inverse ratio ventilation and extra- 381. Erlich JM, Talmor DS, Cartin-Ceba R, et al. Prehospitalization
corporeal CO removal for adult respiratory distress syndrome. antiplatelet therapy is associated with a reduced incidence
2
Am J Respir Crit Care Med. 1994;149:295. of acute lung injury: a population-based cohort study. Chest.
364. Anderson H III, Steimle C, Shapiro M, et al. Extracorporeal 2011;139:289.
life support for adult cardiorespiratory failure. Surgery. 382. Kor DJ, Erlich J, Gong MN, et al. Association of prehospitaliza-
1993;114:161. tion aspirin therapy and acute lung injury: results of a multi-
365. The Australia and New Zealand Extracorporeal Membrane center international observational study of at-risk patients. Crit
Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal Care Med. 2011;39:2393
membrane oxygenation for 2009 Influenza A (H1N1) acute 383. The National Heart, Lung, and Blood Institute. ARDS Clinical
respiratory distress syndrome. JAMA. 2009;302:1888. Trials Network. N Engl J Med. 2014;370:2191-2200.
366. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic 384. The National Heart, Lung, and Blood Institute Acute Respiratory
assessment of conventional ventilatory support versus extra- Distress Syndrome (ARDS) Clinical Trials Network. Initial
corporeal membrane oxygenation for severe adult respiratory trophic vs full enteral feeding in patients with acute lung injury:
failure (CESAR): a multicentre randomised controlled trial. the EDEN randomized trial. JAMA. 2012;307:795.
The Lancet. 2009;374:1351. 385. Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3
367. Hirschl RB, Pranikoff T, Wise C, et al. Initial experience with tatty Acid, γ-linolenic acid, and antioxidant supplementation in
partial liquid ventilation in adult patients with the acute respira- acute lung injury. JAMA. 2011;306:1574.
tory distress syndrome. JAMA. 1996;275:383. 386. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved
368. Leach CL, Greenspan JS, Rubenstein SD, et al. Partial liquid survival of patients with acute respiratory distress syndrome
ventilation with perflubron in premature infants with severe (ARDS). JAMA. 1995;273:306.
respiratory distress syndrome: the LiquiVent Study Group. 387. McHugh L, Milberg J, Whitcomb M, et al. Recovery of function
N Engl J Med. 1996;335:761. in survivors of the acute respiratory distress syndrome. Am J
369. Hirschl RB, Croce M, Gore D, et al. Prospective, randomized, Respir Crit Care Med. 1994;150:90.
controlled pilot study of partial liquid ventilation in adult acute 388. Orme J Jr, Romney JS, Hopkins RO, et al. Pulmonary function
respiratory distress syndrome. Am J Respir Crit Care Med. and health-related quality of life in survivors of acute respi-
2002;165:781. ratory distress syndrome. Am J Respir Crit Care Med. 2003;
370. Hallman M, Spragg R, Harrell JH, et al. Evidence of lung 167:690.
surfactant abnormality in respiratory failure. J Clin Invest. 389. Weinert CR, Gross CR, Kangas JR, et al. Health-related qual-
1982;70:673. ity of life after acute lung injury. Am J Respir Crit Care Med.
371. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress 1997;156:1120.
syndrome. Am Rev Resp Dis. 1993;147:218. 390. Schelling G, Stoll C, Haller M, et al. Health-related quality of
372. Jobe A, Ikegami M. Surfactant for the treatment of respiratory life and posttraumatic stress disorder in survivors of the acute
distress syndrome. Am J Respir Crit Care Med. 1987;136:1256. respiratory distress syndrome. Crit Care Med. 1998;26:651.

Section04-O-ref.indd 11 1/21/2015 11:23:19 AM